Is a complete LTRN research report available?

No complete published report is available for Lantern Pharma Inc. (LTRN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Lantern Pharma Inc. (LTRN)

NASDAQ: LTRN · USD

$2.87

+0.03 (+1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LTRN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	36.6M
Net income (ttm)	-15.9M
EPS (ttm)	-$1.44
Shares out	12.8M
Volume	49,597
Beta	2.29
Price target	$20.0	+596.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -15.9M
EPS (ttm): -$1.44
Market cap: 36.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LTRN indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001763950
Company name	Lantern Pharma Inc.
Country	United States
Country code	US
Cusip	51654W101
Employees	16
Employees Change	-8%
Employees Change Percent	-33.33
Enterprise value	$30M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-06-11
Isin	US51654W1018
Last refreshed	2026-07-24
Market cap	$36.6M
Market cap category	Nano-Cap
Price	$2.87
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	LTRN
Website	https://www.lanternpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-43.91%
FCF yield	-41.6%
P/B ratio	9.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-15.9M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Profit Per Employee	$-994,489
ROA	-73.31
Roa5y	-30.45
ROCE	-482
ROE	-157.4
Roe5y	-54.56
ROIC	-101.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-28.8%
Cagr3y	-14.3%
Cagr5y	-27.1%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$7.2M
Cash	$6.3M
Current Assets	$7.1M
Current Liabilities	$3.8M
Debt	$59,076
Debt Equity	$0.02
Equity	$3.4M
Liabilities	$3.8M
Long Term Assets	$165,807
Long Term Liabilities	$0
Net Cash	$6.3M
Net Cash By Market Cap	$17.29
Net Cash Growth	-67.92%
Net Debt Equity	$-1.82
Tangible Book Value	$3.4M
Tangible Book Value Per Share	$0.31
WACC	16.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.87
Net Working Capital	$-3M
Quick ratio	1.68
Working Capital	$3.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.25%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-28.78%
200-day SMA	3.15
3Y total return	-37.06%
50-day SMA	3.47
50-day SMA vs 200-day SMA	50over200
5Y total return	-79.41%
All Time High	24.84
All Time High Change	-88.45%
All Time High Date	2020-10-12
All Time Low	1.11
All Time Low Change	158.56%
All Time Low Date	2026-03-27
ATR	0.3
Beta	2.29
Beta1y	4.17
Beta2y	2.4
Ch YTD	-5.28
High	2.93
High52	5.74
High52 Date	2025-08-06
High52ch	-50.03%
Low	2.72
Low52	1.11
Low52 Date	2026-03-27
Low52ch	158.56%
Ma50ch	-17.34%
Premarket Change Percent	2.6
Premarket Price	$2.91
Premarket Volume	3,175
Price vs 200-day SMA	-9%
RSI	38.12
RSI Monthly	45.76
RSI Weekly	47.18
Sharpe ratio	0.15x
Sortino ratio	0.27
Total Return	-2.25%
Tr YTD	-5.28
Tr1m	-26.03%
Tr1w	-1.37%
Tr3m	7.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.38
Operating Income	$-16.6M
Price target	$20
Price Target Change	$597

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,820,705%
Float Percent	84.81%
Shares Insiders	3.63%
Shares Institutions	14.15%
Shares Out	12,758,872
Shares Qo Q	-0.57%
Shares Yo Y	2.25%
Short Float	8.59%
Short Ratio	4.45
Short Shares	7.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-16.2M
Average Volume	162,252.6x
Bv Per Share	0.31
CAPEX	$-556
Ch1m	-26.03
Ch1w	-1.37
Ch1y	-28.78
Ch3m	7.09
Ch3y	-37.06
Ch5y	-79.41
Ch6m	-18.7
Change	1.06%
Change From Open	2.5
Close	2.84
Days Gap	-1.41
Depreciation Amortization	16,559
Dollar Volume	142,343.4
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-16.6M
EBITDA	$-16.6M
EPS	$-1.44
F Score	1
FCF	$-15.1M
FCF EV Yield	-50.3x
FCF Per Share	$-1.18
Financing CF	1,498,240
Fiscal Year End	December
Founded	2,013
Investing CF	12,067,742
Ipr	-81.07
Iprfo	-80.81
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	2.94
Ma150ch	-2.45%
Ma20	3.42
Ma20ch	-15.98%
Net CF	-1,459,806
Next Earnings Date	2026-08-12
Open	2.8
Optionable	Yes
Position In Range	71.43
Post Close	2.87
Postmarket Change Percent	1.05
Postmarket Price	$2.9
Ppne	84,890
Pre Close	2.84
Price Date	2026-07-23
Ptbv Ratio	10.52
Relative Volume	0.31x
Share Based Comp	1,171,742
Tr6m	-18.7%
Us State	Texas
Volume	49,597

Lantern Pharma Inc. (LTRN)

Coverage state: Market snapshot only — no published research

Generate the first LTRN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LTRN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LTRN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LTRN

Frequently asked questions